BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 3918869)

  • 1. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
    Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
    Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of glioma cells to interferon-gamma: increase in class II RNA, protein and mixed lymphocyte reaction-stimulating ability.
    Takiguchi M; Ting JP; Buessow SC; Boyer C; Gillespie Y; Frelinger JA
    Eur J Immunol; 1985 Aug; 15(8):809-14. PubMed ID: 2411569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of the induction of HLA-DR expression by human immune interferon on glioma cell lines and their clones.
    Piguet V; Carrel S; Diserens AC; Mach JP; de Tribolet N
    J Natl Cancer Inst; 1986 Feb; 76(2):223-8. PubMed ID: 3080635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines.
    Virelizier JL; Perez N; Arenzana-Seisdedos F; Devos R
    Eur J Immunol; 1984 Jan; 14(1):106-8. PubMed ID: 6420168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
    Basham TY; Merigan TC
    J Immunol; 1983 Apr; 130(4):1492-4. PubMed ID: 6403609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC antigen expression in human oral squamous carcinoma cell lines.
    Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
    J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
    Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
    J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma.
    Guerry D; Alexander MA; Elder DE; Herlyn MF
    J Immunol; 1987 Jul; 139(1):305-12. PubMed ID: 3108402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon.
    Masuyama J; Minato N; Kano S
    J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential susceptibility of HLA class II antigens induced by gamma-interferon in human neuroblastoma cell lines.
    Sugimoto T; Horii Y; Hino T; Kemshead JT; Kuroda H; Sawada T; Morioka H; Imanishi J; Inoko H
    Cancer Res; 1989 Apr; 49(7):1824-8. PubMed ID: 2493986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
    Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
    Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.